All In Biotech

Drug Trial Radar · NCT07081958

A Study Evaluating the Effect of Daily Oral Tifeglipron (RO7795081) in Participants With Obesity or Overweight With at Least One Weight-Related Comorbidity

A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multi-Center, Phase II Study to Evaluate the Efficacy, Safety, and Tolerability of Once-Daily RO7795081 Administered for 38 Weeks to Participants With Obesity or Overweight With at Least One Weight-Related Comorbidity

Last checked: Nov 20, 2026Latest source record: Nov 12, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 352 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

352

Actual

Start

Jul 29, 2025

Primary completion

Apr 28, 2026

Study completion Jul 30, 2026

Sponsor

Lead sponsor
Hoffmann-La RocheRoche (Genentech) (RHHBY)
Sponsor type
Industry
First posted
Jul 24, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This multicenter, randomized, double-blind, placebo-controlled, parallel-group, dose-range-finding, Phase II study aims to evaluate the efficacy, tolerability, and safety of tifeglipron (RO7795081) for chronic weight management in adult participants with obesity or overweight with at least one weight-related comorbidity, but without diabetes mellitus.

Conditions

  • Obesity or Overweight

Interventions

  • TifeglipronDrug

    Tifeglipron will be administered orally once daily, according to the randomized dosing regimen, during the 38-week treatment period.

  • PlaceboDrug

    Placebo matching each tifeglipron dosing regimen arm will be administered orally once daily during the 38-week treatment period.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percent Change in Body Weight From Baseline to Week 30Time frame: Baseline to Week 30

Locations

36 sites in 1 country. Site status is shown where the registry gives one.

  • Pinnacle Research Group

    Anniston, Alabama

  • Orange County Research Center

    Lake Forest, California

  • Prospective Research Innovations Inc.

    Rancho Cucamonga, California

  • Asclepes Research Centers

    Sherman Oaks, California

  • Encompass Clinical Research

    Spring Valley, California

  • Chase Medical Research

    Waterbury, Connecticut

  • Emerson Clinical Research Institute LLC

    Washington D.C., District of Columbia

  • K2 Medical Research-Winter Garden

    Clermont, Florida

  • K2 Medical Research-Maitland

    Maitland, Florida

  • Rophe Adult and Pediatric Medicine/SKYCRNG

    Union City, Georgia

  • Accellacare of Duly Health and Care

    Oak Lawn, Illinois

  • Accellacare of McFarland

    Ames, Iowa

  • Mercury Street Medical Group, PLLC

    Butte, Montana

  • Neurobehavioral Research, Inc.

    Cedarhurst, New York

  • Accellacare of Cary - Cary Medical Group

    Cary, North Carolina

  • Accellacare - Hickory

    Hickory, North Carolina

  • Accellacare of Raleigh

    Raleigh, North Carolina

  • Accellacare of Rocky Mount

    Rocky Mount, North Carolina

  • Accellacare of Salisbury

    Salisbury, North Carolina

  • Accellacare of Piedmont Healthcare

    Statesville, North Carolina

  • Accellacare of Wilmington, LLC

    Wilmington, North Carolina

  • Accellacare Research of Winston Salem

    Winston-Salem, North Carolina

  • Alliance for Multispecialty Research, LLC (AMR Norman)

    Norman, Oklahoma

  • Tristar Clinical Investigations

    Philadelphia, Pennsylvania

  • Internal Medicine and Pediatrics Associates of Bristol

    Bristol, Tennessee

  • Alliance for Multispecialty Research. LLC

    Knoxville, Tennessee

  • Accellacare of Knoxville

    Knoxville, Tennessee

  • Knoxville-Summit-Halls Family Practice

    Knoxville, Tennessee

  • Clinical Research Associates

    Nashville, Tennessee

  • Texas Diabetes & Endocrinology, P.A.

    Austin, Texas

  • Apex Mobile Clinical Research

    Bellaire, Texas

  • Velocity Clinical Research

    Dallas, Texas

  • Juno Research, LLC

    Houston, Texas

  • Consano Clinical Research

    Shavano Park, Texas

  • Chrysalis Clinical Research

    St. George, Utah

  • Manassas Clinical Research Center

    Manassas, Virginia

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.